Biểu đồ giá cổ phiếu ANTH
ANTH Dự đoán giá cổ phiếu
Anthera Pharmaceuticals Inc
$0
0%
$0
Khi đóng cửa: May 13, 16:00:00 GMT-4
$0
0%
$0
Phiên sau giờ: May 13, 20:00:00 GMT-4
Quay lại
Anthera Pharmaceuticals Inc (ANTH) Dự đoán giá cổ phiếu
Thống kê chính
Giá đóng cửa trước
$0.0002
Giá mở cửa
$0.0001
Phạm vi ngày
$0.0001 - $0.0002
Phạm vi 52 tuần
$0 - $0.001
Khối lượng
23.8K
Khối lượng trung bình
12.3K
Tỷ suất cổ tức
--
EPS (TTM)
-1.63
Vốn hóa thị trường
$5.2K
ANTH là gì?
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines to treat serious and life-threatening diseases. The firm has two Phase III product candidates, liprotamase also known as Sollpura and blisibimod. Sollpura is a non-porcine investigational Pancreatic Enzyme Replacement Therapy (PERT) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (EPI), often seen in patients with cystic fibrosis and other conditions. Blisibimod targets B-cell activating factor (BAFF), which has been shown to be elevated in a range of B-cell mediated autoimmune diseases, including systemic lupus erythematosus (SLE), or lupus, Immunoglobulin A nephropathy (IgA) nephropathy, lupus nephritis and others.
